Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Genome-wide DNA methylation profiles in hepatocellular carcinoma.

Shen J, Wang S, Zhang YJ, Kappil M, Wu HC, Kibriya MG, Wang Q, Jasmine F, Ahsan H, Lee PH, Yu MW, Chen CJ, Santella RM.

Hepatology. 2012 Jun;55(6):1799-808. doi: 10.1002/hep.25569. Epub 2012 Apr 24.

2.

Exploring genome-wide DNA methylation profiles altered in hepatocellular carcinoma using Infinium HumanMethylation 450 BeadChips.

Shen J, Wang S, Zhang YJ, Wu HC, Kibriya MG, Jasmine F, Ahsan H, Wu DP, Siegel AB, Remotti H, Santella RM.

Epigenetics. 2013 Jan;8(1):34-43. doi: 10.4161/epi.23062. Epub 2012 Dec 3.

3.

Aberrant DNA methylation profile and frequent methylation of KLK10 and OXGR1 genes in hepatocellular carcinoma.

Lu CY, Hsieh SY, Lu YJ, Wu CS, Chen LC, Lo SJ, Wu CT, Chou MY, Huang TH, Chang YS.

Genes Chromosomes Cancer. 2009 Dec;48(12):1057-68. doi: 10.1002/gcc.20708.

PMID:
19760608
4.

Genome-wide aberrant DNA methylation of microRNA host genes in hepatocellular carcinoma.

Shen J, Wang S, Zhang YJ, Kappil MA, Chen Wu H, Kibriya MG, Wang Q, Jasmine F, Ahsan H, Lee PH, Yu MW, Chen CJ, Santella RM.

Epigenetics. 2012 Nov;7(11):1230-7. doi: 10.4161/epi.22140. Epub 2012 Sep 13.

5.

Genome-wide DNA methylation analysis in hepatocellular carcinoma.

Yamada N, Yasui K, Dohi O, Gen Y, Tomie A, Kitaichi T, Iwai N, Mitsuyoshi H, Sumida Y, Moriguchi M, Yamaguchi K, Nishikawa T, Umemura A, Naito Y, Tanaka S, Arii S, Itoh Y.

Oncol Rep. 2016 Apr;35(4):2228-36. doi: 10.3892/or.2016.4619. Epub 2016 Feb 11.

PMID:
26883180
6.

Genome-wide analysis of DNA methylation identifies novel cancer-related genes in hepatocellular carcinoma.

Shitani M, Sasaki S, Akutsu N, Takagi H, Suzuki H, Nojima M, Yamamoto H, Tokino T, Hirata K, Imai K, Toyota M, Shinomura Y.

Tumour Biol. 2012 Oct;33(5):1307-17. doi: 10.1007/s13277-012-0378-3. Epub 2012 Mar 29.

PMID:
22457049
7.

Genome-wide methylation analysis and epigenetic unmasking identify tumor suppressor genes in hepatocellular carcinoma.

Revill K, Wang T, Lachenmayer A, Kojima K, Harrington A, Li J, Hoshida Y, Llovet JM, Powers S.

Gastroenterology. 2013 Dec;145(6):1424-35.e1-25. doi: 10.1053/j.gastro.2013.08.055. Epub 2013 Sep 5.

8.

Identification of novel methylation markers in hepatocellular carcinoma using a methylation array.

Shin SH, Kim BH, Jang JJ, Suh KS, Kang GH.

J Korean Med Sci. 2010 Aug;25(8):1152-9. doi: 10.3346/jkms.2010.25.8.1152. Epub 2010 Jul 20.

9.

Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.

Neumann O, Kesselmeier M, Geffers R, Pellegrino R, Radlwimmer B, Hoffmann K, Ehemann V, Schemmer P, Schirmacher P, Lorenzo Bermejo J, Longerich T.

Hepatology. 2012 Nov;56(5):1817-27. doi: 10.1002/hep.25870. Epub 2012 Oct 14.

PMID:
22689435
10.

Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.

Song MA, Tiirikainen M, Kwee S, Okimoto G, Yu H, Wong LL.

PLoS One. 2013;8(2):e55761. doi: 10.1371/journal.pone.0055761. Epub 2013 Feb 20.

11.

Methylation profile of single hepatocytes derived from hepatitis B virus-related hepatocellular carcinoma.

Tao R, Li J, Xin J, Wu J, Guo J, Zhang L, Jiang L, Zhang W, Yang Z, Li L.

PLoS One. 2011;6(5):e19862. doi: 10.1371/journal.pone.0019862. Epub 2011 May 23.

12.

Pharmacological unmasking microarray approach-based discovery of novel DNA methylation markers for hepatocellular carcinoma.

Jung N, Won JK, Kim BH, Suh KS, Jang JJ, Kang GH.

J Korean Med Sci. 2012 Jun;27(6):594-604. doi: 10.3346/jkms.2012.27.6.594. Epub 2012 May 26.

13.

Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis.

Yu J, Ni M, Xu J, Zhang H, Gao B, Gu J, Chen J, Zhang L, Wu M, Zhen S, Zhu J.

BMC Cancer. 2002 Nov 15;2:29. Epub 2002 Nov 15.

14.

Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis.

Lee S, Lee HJ, Kim JH, Lee HS, Jang JJ, Kang GH.

Am J Pathol. 2003 Oct;163(4):1371-8.

15.

Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.

Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.

Clin Cancer Res. 2008 Nov 15;14(22):7405-12. doi: 10.1158/1078-0432.CCR-08-0409.

16.
17.

Genome-wide profiling of DNA methylation and tumor progression in human hepatocellular carcinoma.

Nishida N, Nishimura T, Nakai T, Chishina H, Arizumi T, Takita M, Kitai S, Yada N, Hagiwara S, Inoue T, Minami Y, Ueshima K, Sakurai T, Kudo M.

Dig Dis. 2014;32(6):658-63. doi: 10.1159/000367982. Epub 2014 Oct 29.

PMID:
25376281
18.

High-throughput assessment of CpG site methylation for distinguishing between HCV-cirrhosis and HCV-associated hepatocellular carcinoma.

Archer KJ, Mas VR, Maluf DG, Fisher RA.

Mol Genet Genomics. 2010 Apr;283(4):341-9. doi: 10.1007/s00438-010-0522-y. Epub 2010 Feb 18.

19.

Concordant hypermethylation of intergenic microRNA genes in human hepatocellular carcinoma as new diagnostic and prognostic marker.

Anwar SL, Albat C, Krech T, Hasemeier B, Schipper E, Schweitzer N, Vogel A, Kreipe H, Lehmann U.

Int J Cancer. 2013 Aug 1;133(3):660-70. doi: 10.1002/ijc.28068. Epub 2013 Mar 4.

20.

Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.

Moribe T, Iizuka N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M.

Int J Oncol. 2008 Nov;33(5):949-58.

PMID:
18949357

Supplemental Content

Support Center